This industry size reflects growing investments in innovative treatment options and regulatory approvals that are shaping the future trajectory of the market.
Market Size and Overview
The cannabis use disorder market is estimated to be valued at USD 1.80 Bn in 2025 and is expected to reach USD 3.40 Bn by 2032, growing at a compound annual growth rate (CAGR) of 9.5% from 2025 to 2032.
This growth underscores expanding Cannabis Use Disorder Market drivers such as surging cannabis consumption and increasing emphasis on effective therapy options. The market report highlights significant market trends focusing on digital therapeutics and novel pharmacological interventions, enhancing the market scope and revenue potential across various regions.
Current Event & Its Impact on Market
I. Advancement in Regulatory Approvals and Therapeutic Innovations
A. FDA Accelerated Approval for Cannabis Use Disorder Medications - Potential impact on Market: Regulatory acceleration in 2024 has enabled faster market entry for therapeutic candidates, driving market growth and increasing market share for key players, particularly pharmaceutical companies focusing on novel cannabinoid receptor antagonists.
B. Expansion of Telehealth-based Treatment Models - Potential impact on Market: Nano-level shifts towards virtual care are enhancing treatment accessibility, positively influencing market dynamics by broadening patient reach, boosting industry size and revenue streams.
C. Introduction of Digital Therapeutics Platforms - Potential impact on Market: Integrating AI and mobile health applications is addressing market challenges related to treatment adherence, providing significant market opportunities for new entrants.
II. Geopolitical and Economic Developments Affecting Treatment Costs and Supply Chains
A. US-Canada Regulatory Coordination on Cannabis Treatment Drugs - Potential impact on Market: Enhanced cross-border regulatory harmonization is facilitating smoother supply chain operations, optimizing market growth strategies and reducing market restraints related to compliance.
B. Rising Raw Material Costs Due to Global Supply Disruptions - Potential impact on Market: Macroeconomic factors have led to increased material prices, affecting market revenue and compelling market players to innovate in cost efficiency.
C. Emergence of Regional Centers of Excellence in Addiction Treatment - Potential impact on Market: Creating concentrated clusters focused on cannabis use disorder treatment boosts regional market segments, advancing industry trends in targeted therapeutic development.
Impact of Geopolitical Situation on Supply Chain
A prominent use case reflecting geopolitical impact is the 2024 supply chain disruption caused by trade restrictions on botanical raw materials essential for producing cannabinoid-based pharmaceuticals. For instance, reduced exports from key cultivation regions in South America led to increased lead times and manufacturing costs for companies like Corbus Pharmaceuticals in the US. This disruption strained supply reliability, temporarily hindering market revenue and compelling market companies to diversify sourcing strategies, highlighting a critical market challenge and shaping future market growth strategies through vertical integration.
SWOT Analysis
Strengths:
- Increasing adoption of evidence-based treatments driven by robust clinical trials in 2024 demonstrating efficacy improvements.
- Strategic collaborations among market companies enhancing R&D, evident from Pfizer and Zynerba Pharmaceuticals’ partnerships on cannabinoid analog therapies.
- Growing patient awareness leading to expanding market revenue and business growth.
Weaknesses:
- Persisting regulatory fragmentation across regions limits seamless market expansion and constrains market share.
- High treatment costs remain a market restraint, reducing accessibility in lower-income segments.
- Limited availability of standardized treatment protocols affects uniform market dynamics.
Opportunities:
- Rising investment in digital therapeutics offers new market opportunities with scalable patient engagement solutions.
- Increasing global cannabis legalization trends support expanding industry size and market segments.
- Integration of AI for personalized treatment plans expected to revolutionize future market trends.
Threats:
- Geopolitical instability causing raw material supply disruptions and impacting market revenue.
- Stigma around cannabis use disorder treatments posing market challenges to adoption and reimbursement.
- Competitive pressure from alternative substance abuse therapies may limit market growth potential.
Key Players
- Aelis Farma
- Indivior
- Pfizer
- Corbus Pharmaceuticals
- Zynerba Pharmaceuticals
Recent strategic activities include:
- Pfizer’s investment in biomarker-driven clinical trials during 2025 has accelerated pipeline development, improving the market forecast for cannabinoid antagonists.
- Indivior’s 2024 launch of a telehealth-integrated treatment platform has enhanced patient retention, positively affecting market revenue and share.
- Zynerba Pharmaceuticals' technological collaboration to refine transdermal delivery systems resulted in improved therapeutic outcomes, advancing market growth strategies.
FAQs
1. Who are the dominant players in the Cannabis Use Disorder Market?
Leading market players include Aelis Farma, Indivior, Pfizer, Corbus Pharmaceuticals, and Zynerba Pharmaceuticals, who actively invest in R&D and innovative treatment delivery models.
2. What will be the size of the Cannabis Use Disorder Market in the coming years?
The market size is expected to grow from USD 1.80 billion in 2025 to USD 3.40 billion by 2032, driven by expanding awareness and regulatory advancements.
3. Which end user industry has the largest growth opportunity?
Healthcare providers focusing on addiction treatment clinics and telehealth services present the largest growth opportunities due to increasing demand for accessible cannabis use disorder therapies.
4. How will market development trends evolve over the next five years?
Market trends suggest a shift towards digital therapeutics, integration of AI in treatment protocols, and expanded regulatory approvals, fueling sustained market growth and enhanced business growth.
5. What is the nature of the competitive landscape and challenges in the Cannabis Use Disorder Market?
The landscape is characterized by strong innovation focus but faces challenges such as fragmented regulations, raw material supply disruptions, and treatment stigma affecting market share.
6. What go-to-market strategies are commonly adopted in the Cannabis Use Disorder Market?
Market companies emphasize strategic partnerships, technological integration (notably telehealth and AI), and geographic diversification to optimize market penetration and revenue.
‣ Get more insights on: Cannabis Use Disorder Market
‣ Get this Report in Japanese Language: 大麻使用障害市場
‣ Get this Report in Korean Language: 대마사용장애시장
‣ Read More Related Articles: Mitral Valve Annuloplasty Rings - Growth in Heart Disease
Author Bio:
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemical and materials, defense and aerospace, consumer goods, etc. (https://www.linkedin.com/in/money-singh-590844163 )
